secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001493152-24-035166
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics raises $4.45M in public offering; sold shares and pre-funded warrants at $0.55
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.45M from offering of 3,078,378 shares and 5,028,206 pre-funded warrants.
- Net proceeds ~$3.79M after placement agent fees (7%) and estimated expenses.
- Proceeds to fund ONP-002 development for mild traumatic brain injury and general working capital.
- Post-offering shares outstanding: 8,659,071 common shares plus 5,028,206 pre-funded warrants.
- Placement agent Dawson James receives 7% cash fee and warrants for 5% of securities sold at 125% of offering price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224035166/0001493152-24-035166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224035166/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer